Multiple Myeloma: Choosing the best treatment regimen in newly diagnosed patients - Part 1

December 06, 2023 00:20:43
Multiple Myeloma: Choosing the best treatment regimen in newly diagnosed patients - Part 1
COR2ED - Oncology Medical Conversation
Multiple Myeloma: Choosing the best treatment regimen in newly diagnosed patients - Part 1

Dec 06 2023 | 00:20:43

/

Show Notes

In this medical education podcast series, myeloma experts Dr. Joshua Richter (Assistant Professor of Medicine and Director of Myeloma at the Tisch Cancer Institute at the Icahn School of Medicine and the Blavatnik Family Chelsea Medical Center at Mount Sinai in New York, USA) and Dr. Karthik Ramasamy (Haematologist and Associate Professor of Haematology at the Oxford University Hospitals in London, UK) discuss their experience and views on choosing the best treatment every time in multiple myeloma.

In this first episode, Dr. Richter and Dr. Ramasamy discuss how to select the best approach in newly diagnosed patients with multiple myeloma. The experts look at transplant eligibility as one of the key factors in deciding which treatment to start with in the front-line setting. They discuss the potential for personalising therapy in newly diagnosed patients, both in the transplant setting as well as in patients who are not eligible for transplantation.

They also comment on the impact of MRD negativity in clinical practice and agree that the goal of treatment is to induce deep remissions. However, which patient needs triple or quadruplet therapy to achieve this goal is still unclear and the risk-benefit profile needs to be considered for each individual patient.

The final topic that the experts share their points of view on is continuous vs fixed-duration maintenance therapy.

Other Episodes

Episode

December 06, 2023 00:22:00
Episode Cover

Prostate cancer: Highlights from ASCO GU, ASCO and EAUN 2022

In this podcast Dr Jason Alcorn and Jennifer Sutton discuss the oncology nursing highlights from ASCO GU, ASCO and EAUN 2022.  The experts discuss:...

Listen

Episode

December 06, 2023 00:30:42
Episode Cover

HCC: VEGFR-TKI monotherapy for unresectable or advanced HCC in 1st line setting

Prof. Josep Llovet and Prof. Stephen L. Chan discuss a very interesting topic about the use of the VEGFR TKIs monotherapy in the treatment...

Listen

Episode

December 06, 2023 00:23:12
Episode Cover

Breast cancer: Oral SERDs in ER+ BC. Part 1 - Efficacy, safety and the treatment landscape

In this podcast, the experts give an overview of  the EMERALD trial  and present elacestrant as the first, and currently only, oral SERD to...

Listen